DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Kuhn DJ, Chen Q, Voorhees PM. , et al.
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma.
Blood 2007;
110 (09) 3281-3290
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.